Early Detection Research Network

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

No abstract available.

Agorreta J, Ajona D, Camps C, Corrales L, Jantus-Lewintre E, Lozano MD, Massion PP, Montuenga LM, Pajares MJ, Perez-Gracia JL, Pio R, Torre W, Zulueta JJ, de-Torres JP


J. Natl. Cancer Inst., 2013, 105 (18)